FGF23 and hearing loss disorder: In our next study, we plan to use a rat model of hearing impairment in kidney failure to test this hypothesis by targeting the expression of FGF23/D-serine in kidney tissue and cochlea, downstream signaling pathways, and its regulation of NMDAR.